Life Sciences Solution from Promega Simplifies Assay
FREMONT, CA: Promega Corporation, a company providing innovative solutions and technical support to life sciences industry announced GloMax Discover. It is an integrated multimode detection plate reader system providing superior sensitivity, performance, and flexibility with minimal user intervention. The product is latest addition to its 2500 product catalogue helping scientists across the globe in breaking new frontiers in acquiring knowledge in genomics, proteomics, cellular analysis, molecular diagnostics and human identification. Based in U.S. and having branches in 15 countries and over 50 distributors globally, the company is looking forward to play a pivotal role in the evolution of life sciences industry.
Keeping an elegant, simplified and high performance systems solution in mind, Promega developed GloMax Discover software coupled with the exhaustive cell and biochemical assay portfolio that offers scientists an integrated system to easily study cell signaling and metabolism, while monitoring cell viability, apoptosis, and cytotoxicity, or to study gene expression with a wide variety of reporter assays
The system offers strong and weak bioluminescence experimental samples, superior luminescence sensitivity and low well-to-well cross talk. The software allows flexible use of filters and seamless integration with bioluminescent assays from Promega. The platform used with Pierce 660nm Protein Assay quickly and does a precise measurement of protein concentration in solution.
GloMax Discover provides simplified navigation through the control options, preloaded assay protocols, and drag-and-drop protocol customization. The platform supports export of results to a local data network, external flash drive, internet cloud-based server, and Laboratory Information Management System. Technical elements of a 21 CFR Part-11-compliant system are also made available for use in the required laboratory workflows.
"Scientific discoveries not only require the right type of assay to achieve the necessary sensitivity, dynamic range, and reproducibility, they require the right type of instrument. Instruments with enhanced optical capability, such as our GloMax systems with high quality luminescence, enable superior assay performance and experimental design," says Michael Bjerke, Promega Global Product Manager, Detection.
By Leni Kaufman, VP & CIO, Newport News Shipbuilding
By George Evans, CIO, Singing River Health System
By John Kamin, EVP and CIO, Old National Bancorp
By Elliot Garbus, VP-IoT Solutions Group & GM-Automotive...
By Gregory Morrison, SVP & CIO, Cox Enterprises
By Alberto Ruocco, CIO, American Electric Power
By Sam Lamonica, CIO & VP Information Systems, Rosendin...
By Sergey Cherkasov, CIO, PhosAgro
By Pascal Becotte, MD-Global Supply Chain Practice for the...
By Stephen Caulfield, Executive Director, Global Field...
By Shamim Mohammad, SVP & CIO, CarMax
By Ronald Seymore, Managing Director, Enterprise Performance...
By Brad Bodell, SVP and CIO, CNO Financial Group, Inc.
By Jim Whitehurst, CEO, Red Hat
By Clark Golestani, EVP and CIO, Merck
By Scott Craig, Vice President of Product Marketing, Lexmark...
By Dave Kipe, SVP, Global Operations, Scholastic Inc.
By Meerah Rajavel, CIO, Forcepoint
By Amit Bahree, Executive, Global Technology and Innovation,...
By Greg Tacchetti, CIO, State Auto Insurance